Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 2
2018 4
2019 5
2020 4
2021 2
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy.
Panian J, Saidian A, Hakimi K, Ajmera A, Anderson WJ, Barata P, Berg S, Signoretti S, Lee Chang S, D'Andrea V, George D, Dzimitrowicz H, El Zarif T, Emamekhoo H, Gross E, Kilari D, Lam E, Lashgari I, Psutka S, Rauterkus GP, Shabaik A, Thapa B, Wang L, Weise N, Yim K, Zhang T, Derweesh I, McKay RR. Panian J, et al. Among authors: yim k. Oncologist. 2023 Jun 27:oyad166. doi: 10.1093/oncolo/oyad166. Online ahead of print. Oncologist. 2023. PMID: 37368355 Free article.
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy.
Yim K, Melnick K, Mott SL, Carvalho FLF, Zafar A, Clinton TN, Mossanen M, Steele GS, Hirsch M, Rizzo N, Wu CL, Mouw KW, Wszolek M, Salari K, Feldman A, Kibel AS, O'Donnell MA, Preston MA. Yim K, et al. Urol Oncol. 2023 Nov;41(11):458.e1-458.e7. doi: 10.1016/j.urolonc.2023.06.018. Epub 2023 Sep 9. Urol Oncol. 2023. PMID: 37690933
Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Localized Kidney Cancer: Early Outcomes from a Prospective Phase 1 Trial and Supplemental Cohort.
Yim K, Hsu SH, Nolazco JI, Cagney D, Mak RH, D'Andrea V, Singer L, Williams C, Huynh E, Han Z, Martin N, Nguyen P, Kibel AS, Choueiri TK, Chang SL, Leeman JE. Yim K, et al. Eur Urol Oncol. 2024 Feb;7(1):147-150. doi: 10.1016/j.euo.2023.07.002. Epub 2023 Jul 22. Eur Urol Oncol. 2024. PMID: 37487813 Clinical Trial.
Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis.
Yim K, Aron M, Rha KH, Simone G, Minervini A, Challacombe B, Schips L, Berardinelli F, Quarto G, Mehrazin R, Patel D, Patel S, Bindayi A, Ashrafi AN, Desai M, Alqahtani A, Gallucci M, Sulek J, Mari A, De Luyk N, Anele U, Autorino R, Porpiglia F, Sundaram CP, Gill IS, Perdona S, Derweesh IH. Yim K, et al. Eur Urol Focus. 2021 Sep;7(5):1107-1114. doi: 10.1016/j.euf.2020.10.011. Epub 2020 Nov 25. Eur Urol Focus. 2021. PMID: 33249089
25 results